Treatment for Advanced Ovarian Cancer Effective
Links shared publicly online about this topic.
- 1,113total visits
Treatment for Advanced Ovarian Cancer Effective
View full resource at disabled-world.com
Tags: Cancer, Ovarian Cancer, Women's Health
Most Recently Shared on June 7, 2010 at 7:16 pm By:
Treatment for Advanced Ovarian Cancer Effective: New treatment regimen shown effective against advanced ovarian ca... http://bit.ly/asdHX2
Also Shared By:
Eisai breast cancer drug still viewed as not cost effective by NICE - Pharmaceutical and Biotechnology News - Pharma Letter
thepharmaletter.com — “In a third rejection, the UK drug watchdog the National Institute for Health and clinical Excellence (NICE) has issued new guidance not recommending Halaven (eribulin), from Japanese drug major Eisai (TYO: 4523), for the treatment of locally advanced or m” View full resource at thepharmaletter.com
Most Recently Shared on April 3, 2012 at 12:13 pm By:
Even w/discount MT @ThePharmaLetter: NICE still views Eisai breast cancer drug Halaven as not cost effective http://t.co/Bkd28AWx #pharma
Advanced Ovarian Cancer: Multiparametric MR Imaging Demonstrates Response- and Metastasis-specific Effects
radiology.rsna.org — “Advanced Ovarian Cancer: Multiparametric MR Imaging Demonstrates Response- and Metastasis-specific Effects” View full resource at radiology.rsna.org
Most Recently Shared on March 22, 2012 at 6:46 am By:
Advanced Ovarian Cancer: Multiparametric MR Imaging Demonstrates Response- and Metastasis-specific Effects [Geni... http://t.co/FYfxmOD8
Arch Dermatol -- Abstract: Panniculitis Associated With Dermatomyositis and Recurrent Ovarian Cancer, March 19, 2012, Girouard et al. 0 (2012): archdermatol.2012.288v1
archderm.ama-assn.org — “Archives of Dermatology is a monthly professional medical journal published by the American Medical Association. Archives of Dermatology publishes original, peer-reviewed reports and discussions that address the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery” View full resource at archderm.ama-assn.org
Most Recently Shared on March 20, 2012 at 12:41 pm By:
Panniculitis Associated With Dermatomyositis and Recurrent Ovarian Cancer [Observation]: Conclusions Although p... http://t.co/Uc8Yiazv
Ovarian Cancer
springer.com — “Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of ...” View full resource at springer.com
Most Recently Shared on March 16, 2012 at 6:27 pm By:
Ovarian Cancer: Second Editionseries:Cancer Treatment and ResearchOvarian carcinoma continues to be responsible ... http://t.co/GanmC9SK
Leukemia gene mutations linked to survival odds - Yahoo! News
news.yahoo.com — “From Yahoo! News: (Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research. Two studies, published in the latest edition of the New England Journal of Medicine, show that genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets. ...” View full resource at news.yahoo.com
Most Recently Shared on March 15, 2012 at 6:42 pm By:
Leukemia gene mutations linked to survival odds - (Reuters) - Advances in genetic profiling are paving the way for m... http://t.co/0EfukO57
Leukemia gene mutations linked to survival odds - Yahoo! News
news.yahoo.com — “From Yahoo! News: (Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research. Two studies, published in the latest edition of the New England Journal of Medicine, show that genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets. ...” View full resource at news.yahoo.com
Most Recently Shared on March 15, 2012 at 5:57 pm By:
Leukemia gene mutations linked to survival odds: (Reuters) - Advances in genetic profiling are paving the way fo... http://t.co/NSC3KcOm
Leukemia gene mutations linked to survival odds
health.yahoo.net — “(Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research.” View full resource at health.yahoo.net
Most Recently Shared on March 15, 2012 at 5:55 pm By:
Leukemia gene mutations linked to survival odds: (Reuters) - Advances in genetic profiling are paving the way fo... http://t.co/lIf45igw
Leukemia study links gene mutations to survival chances | Health & Fitness | Life | Toronto Sun
torontosun.com — “Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research.” View full resource at torontosun.com
Most Recently Shared on March 15, 2012 at 4:56 pm By:
Leukemia study links gene mutations to survival chances: Advances in genetic profiling are paving the way for mo... http://t.co/aNUkXYIa
Leukemia gene mutations linked to survival odds - Yahoo! News
news.yahoo.com — “From Yahoo! News: (Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research. Two studies, published in the latest edition of the New England Journal of Medicine, show that genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets. ...” View full resource at news.yahoo.com
Most Recently Shared on March 14, 2012 at 11:36 pm By:
Leukemia gene mutations linked to survival odds: (Reuters) - Advances in genetic profiling are paving the way fo... http://t.co/g3SXV91M
Leukemia gene mutations linked to survival odds | Reuters
reuters.com — “(Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new” View full resource at reuters.com
Most Recently Shared on March 14, 2012 at 9:21 pm By:
Leukemia gene mutations linked to survival odds http://t.co/M2HCNVVQ
Leukemia gene mutations linked to survival odds | Reuters
reuters.com — “(Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new” View full resource at reuters.com
Most Recently Shared on March 14, 2012 at 9:13 pm By:
Leukemia gene mutations linked to survival odds http://t.co/Ufz5NLrc
Inlyta (axitinib) Approved For Advanced Kidney Cancer, USA
medicalnewstoday.com — “The US FDA has approved Inlyta (axitinib) for the treatment of advanced renal cell carcinoma, a type of kidney cancer, in patients with whom other drugs have not been effective, the FDA (Food and” View full resource at medicalnewstoday.com
Most Recently Shared on January 27, 2012 at 10:05 pm By:
Inlyta (axitinib) Approved For Advanced Kidney Cancer, USA http://t.co/rGglGwAy #healthnews
Innovative computer algorithm identifies clinically prognostic marker for cancer
news-medical.net — “Researchers at the Stanford University School of Medicine have used an innovative mathematical technique to find markers that effectively predict how deadly a cancer will be. The discovery, which in this case concerned bladder cancer, could lead to faster, less expensive and more accurate analysis of cancer risk and better treatment of the disease.” View full resource at news-medical.net
Most Recently Shared on January 18, 2012 at 8:01 am By:
Ovarian Cancer News: Innovative computer algorithm identifies clinically prognostic marker for cancer: Researche... http://t.co/xC6TYAcw
Faulty proteins may prove significant in identifying new treatments for ovarian cancer
medicalxpress.com — “A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range of ovarian cancer patients, an Oregon Health & Science University Knight Cancer ...” View full resource at medicalxpress.com
Most Recently Shared on January 13, 2012 at 9:02 pm By:
Faulty proteins may prove significant in identifying new treatments for ovarian cancer http://t.co/kx5Z66aY
Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours
news-medical.net — “Circadian Technologies Limited announced today that it has commenced the first Phase 1 clinical trial of its fully human monoclonal antibody against VEGF-C, VGX-100, at a leading US-based cancer treatment centre.” View full resource at news-medical.net
Most Recently Shared on January 9, 2012 at 5:39 am By:
Lung Cancer News: Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours: Circadian Technologies Li... http://t.co/I2cWoG6D
Advertisement


Disabled World
@disabledworld
Treatment for Advanced Ovarian Cancer Effective http://ff.im/-lA8Uw
1 year ago...